We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New Type of Digestive Endoscopy Diagnoses Small, Early Esophageal Cancers without Biopsy

By HospiMedica International staff writers
Posted on 24 Feb 2023

Esophageal cancer poses a serious threat to people's life and health as it is the world’s seventh most common cancer and the sixth deadliest type of cancer. More...

It is a malignant tumor originating from the esophagus that is often detected in an advanced stage, resulting in a high fatality rate and slim chances of survival. This makes it vital to diagnose esophageal cancer in the early stages, although this can be challenging for endoscopists due to the small size and lack of typical features of esophageal cancers. Upon discovering lesions, endoscopists generally take biopsies more than once to confirm their finding, although this process can create complications like mucosal bleeding or perforation.

Digestive endoscopy is extensively used for the observation and diagnosis of digestive tract diseases, including esophageal lesions. However, the relatively lower diagnosis rate of early esophageal cancer using common gastroscopy creates the need for pathological biopsy to achieve a clear diagnosis. Continued advancements in medical equipment for the detection of early esophageal cancer has increased focus on endoscopic observation at the cell level and reduce dependence on pathological biopsy. This has led to the use of endocytoscopy which can enlarge the level of 520 and observe the changes of cells using special staining methods that are harmless, thereby allowing for early detection and diagnosis of esophageal lesions.

Currently, few studies have been carried out on the observation and diagnosis of esophageal cancer under endocytoscopy. Now, researchers at The Second Affiliated Hospital of Baotou Medical College (Baotou, China) who summarized published articles on these studies have found that endocytoscopy for the observation and diagnosis of early esophageal cancer has a high accuracy (95%) and specificity (92%), which is comparable to the efficacy of diagnosis after pathological biopsy. Based on their findings, the researchers recommend the extensive application of cell endoscopy for the observation and diagnosis of esophageal lesions in clinical practice.

Related Links:
Baotou Medical College


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Anesthetic Gas Measurement Module
Scio Four
New
Complete Hip System
Taperloc Complete Hip System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: the deep tissue in vivo sound printing (DISP) platform, which combines ultrasound with low-temperature–sensitive liposomes loaded with crosslinking agents (Photo courtesy of Elham Davoodi and Wei Gao/Caltech)

New Ultrasound-Guided 3D Printing Technique to Help Fabricate Medical Implants

3D bioprinting technologies hold considerable promise for advancing modern medicine by enabling the production of customized implants, intricate medical devices, and engineered tissues designed to meet... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.